We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Strattera May Be Imminent as Court Strikes Down Lilly Patent
Generic Strattera May Be Imminent as Court Strikes Down Lilly Patent
August 17, 2010
Generic versions of Eli Lilly’s attention-deficit hyperactivity disorder drug Strattera could be on their way to market after a federal judge ruled Lilly’s patent on the drug invalid.